Medicine
| ISSN | 1885740X |
|---|---|
| Country | Spain |
| Publisher | Publicaciones Permanyer |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 2007-2021 |
| Website | Visit journal |
CancerChemotherapy Reviews is a new medical publication dedicated to Medical Oncology and HematoOncology which plans to offer updated reviews by international experts with the necessary content and breadth to fully acquaint readers with the latest developments. This review of high educational interest will be published in hardcopy format with each issue containing five previously selected articles on the most recent developments and with a total of three issues a year.CancerChemotherapy Reviews has an Editorial Committee composed of international European and American leaders in Oncology to aid in the selection of subjects and experts.CancerChemotherapy Reviews is published quarterly.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2023 | — | 0.033 | 0.029 |
| 2022 | 0.188 | 0.143 | 0.179 |
| 2021 | — | 0.095 | 0.063 |
| 2020 | 0.333 | 0.174 | 0.114 |
| 2019 | 0.056 | 0.067 | 0.043 |
| 2018 | 0.087 | 0.051 | 0.043 |
| 2015 | — | 0.025 | 0.051 |
| 2014 | 0.031 | — | — |
| 2013 | 0.053 | — | — |
| 2012 | 0.079 | — | — |
| 2011 | 0.026 | — | — |
| 2010 | 0.088 | — | — |
| 2009 | 0.059 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.105 |
| 2022 | 0.119 |
| 2021 | 0.116 |
| 2020 | 0.113 |
| 2019 | 0.104 |
| 2018 | 0.111 |
| 2017 | 0.101 |
| 2016 | 0.101 |
| 2015 | 0.104 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 4.000 |
| 2022 | 3.000 |
| 2021 | 3.000 |
https://www.cancerchemotherapyreviews.com/index.php#,https://www.cancerchemotherapyreviews.com/authors-instructions.php